awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26786667-DD239D04-3EC1-4A6C-AB8B-CF7CCDBCDB4B
Q26786667-DD239D04-3EC1-4A6C-AB8B-CF7CCDBCDB4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786667-DD239D04-3EC1-4A6C-AB8B-CF7CCDBCDB4B
Acute kidney injury: preclinical innovations, challenges, and opportunities for translation
P2860
Q26786667-DD239D04-3EC1-4A6C-AB8B-CF7CCDBCDB4B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786667-DD239D04-3EC1-4A6C-AB8B-CF7CCDBCDB4B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bcdc641d921bb23a5e90d02941df0eb82a7848f9
P2860
Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.